The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Author(s):
Dignass, A.; Assche, G. van; Lindsay, J.O.; Lemann, M.; Soderholm, J.; Colombel, J.F.; Danese, S.; D'Hoore, A.; Gassull, M.; Gomollon, F.; Hommes, D.W.; Michetti, P.; O'Morain, C.; Oresland, T.; Windsor, A.; Stange, E.F.; Travis, S.P.L.; ECCO
Published
2010
Publication type
Article / Letter to editor
Crohn's disease Mesalazine Steroids Budesonide Azathioprine Infliximab Adalimumab Surgery inflammatory-bowel-disease placebo-controlled trial pouch-anal anastomosis tumor-necrosis-factor randomized-controlled trial population-based cohort double-blind trial laparoscopic ileocecal resection steroid-induced remission to-end anastomosis
Date issued
2010-02-28
Language
English
Is part of
Journal of Crohn's and Colitis (2010), Vol. 4, no. 1, p. 28-62
hdl
1887/108485
doi
10.1016/j.crohns.2009.12.002